Skip to Content


In some countries, this medicine may only be approved for veterinary use.

In the US, Depo-Medrol (methylprednisolone systemic) is a member of the drug class glucocorticoids and is used to treat Adrenogenital Syndrome, Allergic Rhinitis, Asthma, Asthma - acute, Asthma - Maintenance, Dermatologic Lesion, Gout - Acute, Immunosuppression, Inflammatory Conditions, Neuralgia, Osteoarthritis, Rheumatoid Arthritis and Shock.

US matches:

Ingredient matches for Depo-Medrol


Methylprednisolone is reported as an ingredient of Depo-Medrol in the following countries:

  • Egypt
  • Lebanon
  • Peru

Methylprednisolone 21-acetate (a derivative of Methylprednisolone) is reported as an ingredient of Depo-Medrol in the following countries:

  • Australia
  • Belgium
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • Colombia
  • Croatia (Hrvatska)
  • Czech Republic
  • Denmark
  • Ecuador
  • Estonia
  • Finland
  • France
  • Georgia
  • Greece
  • Hong Kong
  • Hungary
  • Iceland
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Latvia
  • Lithuania
  • Malaysia
  • Myanmar
  • Netherlands
  • New Zealand
  • Norway
  • Oman
  • Philippines
  • Poland
  • Portugal
  • Slovakia
  • Slovenia
  • South Africa
  • Sweden
  • Switzerland
  • Thailand
  • Turkey
  • United States
  • Vietnam

International Drug Name Search

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.